CPT2 抗体 (AA 212-241)
(5 references)Quick Overview for CPT2 抗体 (AA 212-241) (ABIN1881226)
抗原
See all CPT2 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 212-241
-
预测反应
- Pr
-
纯化方法
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
免疫原
- This CPT2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 212-241 amino acids from the Central region of human CPT2.
-
亚型
- Ig Fraction
-
-
anti-Carnitine Palmitoyltransferase 2 (CPT2) (Internal Region) antibody
CPT2 适用: 人, 小鼠, 大鼠 WB, ELISA, IHC, IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-Carnitine Palmitoyltransferase 2 (CPT2) (AA 1-180) antibodyCPT2 适用: 人 WB, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Carnitine Palmitoyltransferase 2 (CPT2) (AA 141-154) antibodyVerified CPT2 适用: 人, 小鼠, 大鼠 WB, ELISA 宿主: 山羊 Polyclonal unconjugated
anti-Carnitine Palmitoyltransferase 2 (CPT2) (AA 1-658) antibodyCPT2 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-Carnitine Palmitoyltransferase 2 (CPT2) (AA 388-551) antibodyCPT2 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Carnitine Palmitoyltransferase 2 (CPT2) (AA 351-450) antibodyCPT2 适用: 人 WB, ELISA 宿主: 小鼠 Polyclonal unconjugated
anti-Carnitine Palmitoyltransferase 2 (CPT2) (AA 1-658) antibodyCPT2 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Carnitine Palmitoyltransferase 2 (CPT2) (AA 351-450) antibodyCPT2 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 1G7 unconjugated
anti-Carnitine Palmitoyltransferase 2 (CPT2) (AA 452-658) antibodyCPT2 适用: 大鼠 WB, IHC, ICC, IP 宿主: 兔 Polyclonal unconjugated
anti-Carnitine Palmitoyltransferase 2 (CPT2) antibodyCPT2 适用: 人, 小鼠, 大鼠 WB, IHC, IF, IC 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- WB: 1:1000
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
有效期
- 6 months
-
-
-
: "High frequency of ETFDH c.250G>A mutation in Taiwanese patients with late-onset lipid storage myopathy." in: Clinical genetics, Vol. 78, Issue 6, pp. 565-9, (2010) (PubMed).
: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." in: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).
: "Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?" in: Pharmacogenomics, Vol. 11, Issue 7, pp. 959-71, (2010) (PubMed).
: "Malignant hyperthermia-like syndrome and carnitine palmitoyltransferase II deficiency with heterozygous R503C mutation." in: Anesthesia and analgesia, Vol. 109, Issue 4, pp. 1070-2, (2009) (PubMed).
: "Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. ..." in: American journal of human genetics, Vol. 85, Issue 5, pp. 628-42, (2009) (PubMed).
-
: "High frequency of ETFDH c.250G>A mutation in Taiwanese patients with late-onset lipid storage myopathy." in: Clinical genetics, Vol. 78, Issue 6, pp. 565-9, (2010) (PubMed).
-
- CPT2 (Carnitine Palmitoyltransferase 2 (CPT2))
-
别名
- CPT2
-
背景
- The protein encoded by this gene is a nuclear protein which is transported to the mitochondrial inner membrane. Together with carnitine palmitoyltransferase I, the encoded protein oxidizes long-chain fatty acids in the mitochondria. Defects in this gene are associated with mitochondrial long-chain fatty-acid (LCFA) oxidation disorders.
-
分子量
- 73777
-
NCBI登录号
- NP_000089
-
UniProt
- P23786
-
途径
- Regulation of Lipid Metabolism by PPARalpha, Monocarboxylic Acid Catabolic Process
抗原
-
